Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to March 2026, from the company's annual filing with the SEC.
| Salesyearly sales | $2.4B |
| Sales growthchange from the year before | +22.1% |
| Gross marginshare of sales left after the direct cost of what it sells | 25.2% |
| Operating marginshare of sales left after running the business | 6.8% |
| Net marginshare of sales kept as profit | 5.4% |
| Free-cash-flow marginspare cash generated per $100 of sales | -4.9% |
| Return on invested capitalprofit made on each $100 put into the business | 12.3% |
| Return on equityprofit vs. shareholders' accounting value | 12.5% |
| Change in share countnegative = the company is buying back its shares | -1.1% |
2 insiders sold $1.1M (all under pre-arranged plans) on the open market.
| Marion Elaine DChief Financial Officer | Sold (plan)Aug 4 | 5,514 shat $96.41 · $532K |
| Marion Elaine DChief Financial Officer | Sold (plan)Aug 3 | 1,668 shat $95.12 · $159K |
| Marion Elaine DChief Financial Officer | Sold (plan)Jul 29 | 2,818 shat $95.22 · $268K |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy